Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-07

Clinical Trial Update: A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating the early effects, safety, and acceptability of oral Alpibectir in combination with Ethionamide for tuberculo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpibectir
  • Ethionamide (ethionamide)

Snippet

Sponsor: TASK Applied Science | Conditions: Tuberculosis | Phase 2 | Status: RECRUITING